Because of their high frequency and their social and economic impact, chronic respiratory diseases, including COPD, asthma, respiratory allergies and occupational lung diseases represent a major public health problem in the Middle East. Although risk factors like tobacco smoke, vehicle emissions and other indoor and outdoor air pollutants are becoming strictly controlled in the UAE, respiratory disease is still increasing across all age groups. Fortunately however, most respiratory diseases are preventable and treatable and Pharmax will develop and produce a full range f the most modern pharmaceuticals to support the region’s medical specialists.

Product will be updated

Copyright 2020 – Pharmax Pharmaceuticals FZ-LLC. All Rights Reserved.

Ministry of Health Health and Prevention Advertisement License No : IN0W3681-140720 valid till 15/07/2021